Baird Starts Pliant Therapeutics (PLRX) at Outperform, 'We believe there's currently little priced in the stock'
Tweet Send to a Friend
(Updated - April 13, 2023 6:37 AM EDT)
Baird analyst Joel Beatty initiates coverage on Pliant Therapeutics (NASDAQ: PLRX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Baird analyst Joel Beatty initiates coverage on Pliant Therapeutics (NASDAQ: PLRX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
